2.995USD-3.07%Mkt Cap: 27.41M USDP/E: —Last update: 2026-06-01
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered s…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap27.41M USD
Enterprise Value15.87M USD
Revenue (TTM)2.09M USD
Gross Profit-20.02M USD
Net Income (TTM)-26.97M USD
Revenue/Share0.2280 USD
Last Price2.995 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees15
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.29
PEG—
EV/EBITDA—
EV/Revenue7.60
P/S13.78
P/B2.71
EPS (TTM)-3.28
EPS (Forward)-2.42
52W Range
2.8202% of range13.13
52W High13.13 USD
52W Low2.820 USD
Profitability
Gross Margin0.00%
Oper. Margin-1488.86%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-147.98%
ROA-117.87%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-23.45M USD
CapEx (TTM)—
FCF Margin-780.47%
FCF Yield-59.49%
Net Debt-12.92M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio3.36
Quick Ratio2.87
Book Value/Sh1.147 USD
Cash/Share1.396 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateDec 14, 2018
Splits
Last Split2:3
Split DateAug 17, 2023
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)20.33 USD
Target Range9.000 USD – 27.00 USD
# Analysts6
Ownership
Shares Out.9.26M
Float6.29M
Insiders32.84%
Institutions19.43%
Short Interest
Short Ratio6.3d
Short % Float4.37%
Short % Out.3.00%
Shares Short277.90K
Short (prev mo.)274.26K
Technical
SMA 503.755 (-20.2%)
SMA 2006.502 (-53.9%)
Beta-4.47
S&P 52W Chg27.94%
Avg Vol (30d)60.73K
Avg Vol (10d)89.94K
Technical Indicators
RSI (14)37.2
MACD-0.2311
MACD Signal-0.2064
MACD Hist.-0.0247
BB Upper4.169 USD
BB Middle3.439 USD
BB Lower2.708 USD
BB Width42.50%
ATR (14)0.2474 USD
Vol Ratio (20d)0.98x